Category: COVID-19

It Was Already Hard to Find Evusheld, a Covid Prevention Therapy. Now It’s Even Harder.

At least 7 million immunocompromised people could benefit from the monoclonal antibody injections designed to prevent covid-19. The government says it has enough doses for a fraction of those in need ― and it doesn’t have the money to buy more.

Pandemic Medical Innovations Leave Behind People With Disabilities

As the country enters Year 3 of the pandemic emergency, people with disabilities across the U.S. are still finding it difficult to use innovations in telemedicine, teleworking, and testing.

KHN’s ‘What the Health?’: Congress Shelves Covid Funding for Now

The Biden administration’s request for billions more in funding to fight covid-19 hit a snag on Capitol Hill this week, as Democrats objected to Republican demands that money allocated to states but not yet spent be reclaimed. Meanwhile, the big annual spending bill about to cross the finish line addresses other health policy changes, such as giving the FDA authority to regulate “synthetic” nicotine. Joanne Kenen of the Johns Hopkins Bloomberg School of Public Health and Politico, Rachel Cohrs of Stat, and Jessie Hellmann of Modern Healthcare join KHN’s Julie Rovner to discuss these issues and more. Plus, for extra credit, the panelists recommend their favorite health policy stories of the week they think you should read, too.

Two Years In, Covid Leaves Montana Public Health Officials Feeling ‘Watched’

Montanans engage in plenty of spirited political disagreements. But debates about covid-19, public health, and personal liberties have reached a fever pitch, tugging at tightknit towns and making some residents wonder how their communities will survive.

The CDC’s New Guidelines on Covid Risk and Masking Elicit Mixed Feelings

The agency’s updated recommendations lower the level of covid risk for most of the country and therefore the need to mask. But some experts question the strategy.

One California University Has Unified Town and Gown to Fight Covid. Why Haven’t Others?

The University of California-Davis has spent close to $50 million preventing the spread of covid on campus — and among residents and workers in the adjacent city of Davis. By most accounts, this town-gown experiment has paid off nicely.

The NFL Has Been Using an Unproven Measure to Get Players With Covid Back on the Field Fast

Doctors and scientists are debating whether a little-known measure in covid testing should be used to distinguish who is infectious from who isn’t. The NFL adopted the practice, but laboratory professionals caution against its use.

Watch: California’s Top Health Adviser on Learning to Live With Covid

KHN Senior Correspondent Samantha Young joined California Health and Human Services Secretary Mark Ghaly for an engaging conversation about how California moves forward in an environment in which covid persists, but at more manageable levels.

Charts Paint a Grim Picture 2 Years Into the Coronavirus Pandemic

The on-off nature of the pandemic “has led to a lot of the confusion and grumpiness,” says one expert. Another compares it to the exhaustion of the American public when hearing body counts during the Vietnam War.

When Teens Blow Off Parents’ Pleas to Get Vaccinated, the Consequences Can Be Deadly

Kennedy Stonum, a 17-year-old high school junior, resisted getting vaccinated against covid-19, as did 20-year-old Tyler Gilreath, whose mother had nagged him for months to get the shots. Both died.